molecular oncologic imaging, vol.2, no.3, pp.52-55, 2022 (Peer-Reviewed Journal)
Abstract
F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory
differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment
response evaluation for tyrosine kinase inhibitor treatment response evaluation. This case report is
about the treatment response evaluation of a unique patient with multiple unusual metastatic
lesions of RAIR-DTC.